Cytel · 1 day ago
Executive Consultant – Vice President, Quantitative Clinical Pharmacology
United States
Full-time
Remote
Director/Executive
15+ years expCytel is seeking an Executive Consultant – Vice President of Quantitative Clinical Pharmacology to join their Strategic Consulting team. This role involves scientific leadership and strategic advisory, focusing on population modeling and quantitative clinical pharmacology to guide clients in regulatory and clinical development pathways.
ConsultingSoftware
Hiring Manager
Krzysztof Orzechowski
Responsibilities
Serve as an externally recognized expert in Quantitative Clinical Pharmacology, Pop-PK/PK-PD modeling, MIDD, and quantitative regulatory strategies
Lead the development and dissemination of innovative methodologies, contributing to Cytel’s scientific leadership through publications, conference presentations, and webinars
Provide high-level strategic guidance to clients on clinical development plans, regulatory and market access pathways, trial design optimization, and quantitative decision-making
Act as the primary point of contact for major Strategic Consulting accounts, ensuring delivery excellence and long-term partnership development
Identify and pursue new business opportunities across Cytel’s consulting and analytics offerings, shaping solutions that meet revenue, profitability, and client satisfaction objectives
Build and maintain relationships with senior stakeholders, including regulatory agencies (e.g., FDA, EMA), key opinion leaders, and executive-level client personnel
Oversee and contribute to Pop-PK and PK/PD modeling, non-compartmental analysis (NCA), and broader QPP analytical activities
Provide mentorship, technical oversight, and direction to consultants and analysts, building a high-performing quantitative team
Support non-QPP engagements when needed, such as statistical design, adaptive/Bayesian methodologies, simulation-based planning, or data science initiatives
Work closely with Cytel’s business developers, statisticians, software teams, and data scientists to deliver integrated, high-value solutions
Represent QPP expertise within multidisciplinary engagements, ensuring strategic alignment and scientific rigor
Travel as required to engage with clients and internal stakeholders
Qualification
Required
Minimum 5+ years of hands-on QPP experience; 15+ years overall experience in consulting, clinical development, or health research preferred for VP-level responsibilities
Demonstrated leadership in MIDD, Pop-PK/PK-PD modeling, and quantitative strategy within drug development
Experience interacting with regulatory authorities and contributing to regulatory submissions is highly desirable
Proven expertise in Pop-PK/PK-PD modeling, NCA, and interpretation of quantitative pharmacology results for CSR and reporting
Proficiency in Phoenix WinNonlin/NLME, R, and strong understanding of computational and statistical methods used in clinical development
Excellent technical writing, oral communication, and presentation skills; ability to clearly communicate complex quantitative concepts
Strong organizational, analytical, and problem-solving abilities; able to operate effectively in a fast-paced, high-growth environment
Company
Cytel
Our mission is to improve success rates in this endeavor via the optimal design, effective implementation
1001-5000 employees
H1B Sponsorship
Cytel has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (38)
2024 (54)
2023 (37)
2022 (46)
2021 (43)
2020 (33)
Funding
Current Stage
Late StageTotal Funding
$2MKey Investors
New Mountain CapitalMerck Capital Ventures
2021-01-01Series Unknown
2020-12-21Acquired
2017-11-01Private Equity
Leadership Team
Cyrus Mehta
Co-Founder and President
Nitin Patel
Chairman and Chief Technology Officer
Recent News
Adial Pharmaceuticals, Inc
2025-08-14
2025-06-11
Company data provided by crunchbase